flag flag  

author = "Dahlke, F"

Found 19 documents, displaying page 2 of 2

Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1b

Description : Objective: To investigate the relationship between neutralizing antibodies (NAB) and disease progression, relapses, and MR measures of MS. Methods: Sequential serum samples from all 718 patients of the European Study Group in Interferon beta-1b in Secondary Progressive MS were analyzed to investigat...
Repository : UCL Eprints
Language(s) : Undetermined

Interferon-beta 1b in the treatment of secondary progressive MS - Impact on quality of life

Description : Background: The recent randomized, controlled trial of interferon-beta 1b (IFN-beta 1b) in 718 patients with secondary progressive MS (SP-MS) demonstrated a significant effect on the development of disability as evaluated by the physician. Its effect on patient-reported health-related quality of lif...
Repository : UCL Eprints
Language(s) : Undetermined

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis

Description : The recently completed European trial of interferon beta-1b (IFN beta -1b) in patients with secondary progressive multiple sclerosis (SP multiple sclerosis) has given an opportunity to assess the impact of treatment on cerebral atrophy using serial MRI. Unenhanced T-1-weighted brain imaging was acqu...
Repository : UCL Eprints
Language(s) : Undetermined

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis

Description : The recently completed European trial of interferon beta-1b (IFN beta -1b) in patients with secondary progressive multiple sclerosis (SP multiple sclerosis) has given an opportunity to assess the impact of treatment on cerebral atrophy using serial MRI. Unenhanced T-1-weighted brain imaging was acqu...
Repository : UCL Eprints
Language(s) : Undetermined

Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS

Description : Background: The recently completed placebo-controlled multicenter randomized trial of interferon beta-1b (Betaferon) in 718 patients with secondary progressive MS shows significant delay of disease progression and reduction of relapse rate. This study provides an opportunity to assess the level of r...
Repository : UCL Eprints
Language(s) : Undetermined

Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis

Description : Background The beneficial effects of interferon beta have only been shown for patients in the relapsing-remitting phase of multiple sclerosis (MS). The role of interferon beta in the treatment of patients who are in the secondary progressive phase of the disease (SP-MS), and for whom no effective dr...
Repository : UCL Eprints
Language(s) : Undetermined

Found 19 documents, displaying page 2 of 2